[18F]-PBR-06

N/A

Report date: 2026/01/28 20:01:42
NME

Base Information

Drug Name[18F]-PBR-06
Drug Alias Name[18F]-FBRFluorine-18 PBR 06[18F]PBR06 PET[18F]-FBR-06
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Nuclides > Fluorine > 18F +[4] 
Mechanisms of ActionPositron-emission tomography enhancersTranslocator protein modulators
TargetsTranslocator protein
Therapy Area/IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseParkinson Disease +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe Brigham and Women's HospitalNational Institute Of Mental Health
China Registration ClassN/A

Develop Information

Active CompaniesThe Brigham and Women's Hospital
Inactive CompaniesThe Institute For Neurodegenerative Disorders IncMolecular Neuroimaging Llc
Active IndicationsMultiple System AtrophyMultiple Sclerosis
Inactive IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A